Press Release: Rarecells, Inc. Appoints Dr. Neil Kurtz to Board of Directors
NEW YORK – (March 26, 2025) – Rarecells, Inc., a pioneering company in liquid biopsy, is pleased to announce the appointment of Dr. Neil Kurtz to its Board of Directors. Dr. Kurtz, a renowned healthcare entrepreneur and executive, brings over 40 years of experience in the pharmaceutical, contract research, post-acute care, and medical diagnostic sectors. […]
Press Release: Rarecells, Inc. Appoints Dr. Neil Kurtz to Board of Directors Read More »